Velocity’s Allergy and Asthma research site in Overland Park, KS partners with Kansas City Allergy and Asthma Associates, P.A. (KCAA) to conduct clinical trials for investigational products intended to help treat allergies, asthma, immunologic diseases, and related conditions. The area’s premiere provider of allergy and asthma care, the site is easily accessible to thousands of patients, including those established with the practice. KCAA has served the community since 1979, and began conducting clinical trials with Meridian Clinical Research in 2022, shortly before being acquired by Velocity.
All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Kansas City team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research.